CVS Health Corporation (TSX:CVS)
Canada flag Canada · Delayed Price · Currency is CAD
21.28
-0.11 (-0.51%)
Nov 13, 2026, 4:00 PM EST

CVS Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
11,0371,7684,6148,3444,3118,001
Depreciation & Amortization
4,5204,6064,5974,3664,2244,486
Loss (Gain) From Sale of Assets
--247-3492,058-
Asset Writedown & Restructuring Costs
-5,725840152-1,789
Stock-Based Compensation
745535540588447484
Other Operating Activities
-129-274-1,593-388-1,681-352
Change in Accounts Receivable
1,785-3,498-1,301-6,260-2,971-2,703
Change in Inventory
721-1,267-1021,233-1,435735
Change in Accounts Payable
-7883,8552,3353,6184,2602,898
Change in Other Net Operating Assets
817-564-8231,4246,9642,927
Operating Cash Flow
18,70810,6399,10713,42616,17718,265
Operating Cash Flow Growth
105.38%16.82%-32.17%-17.01%-11.43%15.13%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,141-2,832-2,781-3,031-2,727-2,520
Cash Acquisitions
-22-436-95-16,612-139-146
Divestitures
-----1,249-
Investment in Securities
-4,434-2,629-4,838-1,314-1,017-2,717
Other Investing Activities
54261016885122
Investing Cash Flow
-7,543-5,871-7,613-20,889-5,047-5,261

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--1,9195,200--
Long-Term Debt Issued
-3,9697,91310,898-987
Total Debt Issued
-3,9699,83216,098-987
Short-Term Debt Repaid
--2,119--5,000--
Long-Term Debt Repaid
--3,629-4,773-3,166-4,211-10,254
Total Debt Repaid
-5,324-5,748-4,773-8,166-4,211-10,254
Net Debt Issued (Repaid)
-5,324-1,7795,0597,932-4,211-9,267
Issuance of Common Stock
425394361277551549
Repurchase of Common Stock
-188-158-3,208-2,193-3,870-168
Common Dividends Paid
-3,423-3,397-3,373-3,132-2,907-2,625
Other Financing Activities
-59-26-201-79155
Financing Cash Flow
-8,569-4,940-1,1352,683-10,516-11,356

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
2,596-172359-4,7806141,648

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
15,5677,8076,32610,39513,45015,745
Free Cash Flow Growth
147.37%23.41%-39.14%-22.71%-14.58%17.26%
Free Cash Flow Margin
3.72%1.95%1.71%2.92%4.18%5.41%
Free Cash Flow Per Share
12.116.145.018.0610.1711.85
Levered Free Cash Flow
11,8265,9306,90911,07511,93514,783
Unlevered Free Cash Flow
13,7427,8798,75812,73713,36516,347

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3,0482,9912,9092,4182,2392,469
Cash Income Tax Paid
1,7062,1661,7033,5244,1163,195
Change in Working Capital
2,535-1,474109156,8183,857